Alice E. Loper

658 total citations
12 papers, 399 citations indexed

About

Alice E. Loper is a scholar working on Pharmaceutical Science, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Alice E. Loper has authored 12 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmaceutical Science, 2 papers in Infectious Diseases and 2 papers in Molecular Biology. Recurrent topics in Alice E. Loper's work include Drug Solubulity and Delivery Systems (4 papers), Pharmaceutical studies and practices (2 papers) and Mass Spectrometry Techniques and Applications (1 paper). Alice E. Loper is often cited by papers focused on Drug Solubulity and Delivery Systems (4 papers), Pharmaceutical studies and practices (2 papers) and Mass Spectrometry Techniques and Applications (1 paper). Alice E. Loper collaborates with scholars based in United States, United Kingdom and Mexico. Alice E. Loper's co-authors include Gloria Y. Kwei, Linda Novak, Lisa Hettrick, Yunhui Wu, Suhas Shelukar, Karen Thompson, Cindy Chen, Ray Higgins, David Storey and M Hichens and has published in prestigious journals such as Neurology, International Journal of Pharmaceutics and Pharmaceutical Research.

In The Last Decade

Alice E. Loper

11 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alice E. Loper United States	8	234	57	57	53	51	12	399
Nobuyuki Kitamori Japan	11	243 1.0×	87 1.5×	42 0.7×	42 0.8×	10 0.2×	30	426
Karen Engle United States	12	273 1.2×	42 0.7×	18 0.3×	42 0.8×	15 0.3×	15	406
M. Guyot France	12	313 1.3×	66 1.2×	61 1.1×	41 0.8×	6 0.1×	22	552
Doron Friedman Israel	10	200 0.9×	107 1.9×	35 0.6×	47 0.9×	6 0.1×	16	399
Kazuo Noda Japan	10	204 0.9×	45 0.8×	14 0.2×	29 0.5×	9 0.2×	22	356
Suzanne M. Caliph Australia	12	231 1.0×	122 2.1×	19 0.3×	137 2.6×	10 0.2×	24	523
Jennifer L. H. Johnson United States	10	75 0.3×	54 0.9×	91 1.6×	16 0.3×	36 0.7×	16	412
I.R. Wilding United Kingdom	9	255 1.1×	40 0.7×	13 0.2×	49 0.9×	9 0.2×	9	407
Laura Rabinovich‐Guilatt United States	10	123 0.5×	101 1.8×	26 0.5×	15 0.3×	31 0.6×	33	369
Milind M. Narurkar United States	13	128 0.5×	94 1.6×	30 0.5×	74 1.4×	4 0.1×	19	514

Countries citing papers authored by Alice E. Loper

Since Specialization

Citations

This map shows the geographic impact of Alice E. Loper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alice E. Loper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alice E. Loper more than expected).

Fields of papers citing papers by Alice E. Loper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alice E. Loper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alice E. Loper. The network helps show where Alice E. Loper may publish in the future.

Co-authorship network of co-authors of Alice E. Loper

This figure shows the co-authorship network connecting the top 25 collaborators of Alice E. Loper. A scholar is included among the top collaborators of Alice E. Loper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alice E. Loper. Alice E. Loper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Wu, Yunhui, Alice E. Loper, Lisa Hettrick, et al.. (2004). The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human. International Journal of Pharmaceutics. 285(1-2). 135–146. 212 indexed citations

Wu, Yunhui, et al.. (1999). Identification of oxidative degradates of the thrombin inhibitor, 3-(2-phenethylamino)-6-methyl-1-(2-amino-6-methyl-5-methylenecarboxamidomethylpyridinyl)pyrazinone, using liquid chromatography/mass spectrometry and liquid chromatography/tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 20(3). 471–485. 11 indexed citations

Kwei, Gloria Y., et al.. (1998). Lymphatic uptake of MK-386, a sterol 5α-reductase inhibitor, from aqueous and lipid formulations. International Journal of Pharmaceutics. 164(1-2). 37–44. 16 indexed citations

Cartwright, Mark E., et al.. (1996). Improved method for rhesus monkey or rat skin preparation and cryosectioning for topical or transdermal skin distribution studies. Experimental Dermatology. 5(1). 45–48.

Steinberg, Marshall, et al.. (1996). A New Approach to the Safety Assessment of Pharmaceutical Excipients. Regulatory Toxicology and Pharmacology. 24(2). 149–154. 34 indexed citations

Kwei, Gloria Y., Linda Novak, Lisa Hettrick, et al.. (1995). Regiospecific Intestinal Absorption of the HIV Protease Inhibitor L-735,524 in Beagle Dogs. Pharmaceutical Research. 12(6). 884–888. 23 indexed citations

Coleman, R., Klaus W. Lange, Niall Quinn, et al.. (1989). The antiparkinsonian actions and pharmacokinetics of transdermal (+)‐4‐Propyl‐9‐hydroxynaphthoxazine (+ PHNO): Preliminary results. Movement Disorders. 4(2). 129–138. 24 indexed citations

Rupniak, N.M.J., Spencer J. Tye, C.A. Jennings, et al.. (1989). Antiparkinsonian efficacy of a novel transdermal delivery system for (+)-PHNO in MPTP-treated squirrel monkeys. Neurology. 39(3). 329–329. 27 indexed citations

Vlasses, Peter H., Lair G.T. Ribeiro, Heschi H. Rotmensch, et al.. (1985). Initial Evaluation of Transdermal Timolol. Journal of Cardiovascular Pharmacology. 7(2). 245–250. 39 indexed citations

10.

Stavchansky, S. & Alice E. Loper. (1982). Nitrogen-Phosphorous Detection of Phencyclidine in Blood Serum. Journal of Pharmaceutical Sciences. 71(2). 194–196. 4 indexed citations

11.

Stavchansky, S., James T. Doluisio, A. Martin, et al.. (1980). Correlation of in vivo bioavailability of erythromycin stearate tablets with in vitro tests.. PubMed. 69(11). 1307–10. 5 indexed citations

12.

Stavchansky, S., A. Martin, & Alice E. Loper. (1979). Solvent system effects on drug absorption.. PubMed. 24(1). 77–85. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact